358 related articles for article (PubMed ID: 24393810)
1. A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors.
Mattsson C; Svensson P; Sonesson C
Eur J Med Chem; 2014 Feb; 73():177-86. PubMed ID: 24393810
[TBL] [Abstract][Full Text] [Related]
2. Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors.
Pisani L; Catto M; Nicolotti O; Grossi G; Di Braccio M; Soto-Otero R; Mendez-Alvarez E; Stefanachi A; Gadaleta D; Carotti A
Eur J Med Chem; 2013; 70():723-39. PubMed ID: 24231308
[TBL] [Abstract][Full Text] [Related]
3. In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors.
Pisani L; Farina R; Nicolotti O; Gadaleta D; Soto-Otero R; Catto M; Di Braccio M; Mendez-Alvarez E; Carotti A
Eur J Med Chem; 2015 Jan; 89():98-105. PubMed ID: 25462230
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
[TBL] [Abstract][Full Text] [Related]
5. Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.
Legoabe LJ; Petzer A; Petzer JP
Bioorg Chem; 2012 Dec; 45():1-11. PubMed ID: 23064123
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.
Legoabe LJ; Petzer A; Petzer JP
Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of a set of para-substituted 4-phenylpiperidines and 4-phenylpiperazines as monoamine oxidase (MAO) inhibitors.
Pettersson F; Svensson P; Waters S; Waters N; Sonesson C
J Med Chem; 2012 Apr; 55(7):3242-9. PubMed ID: 22385498
[TBL] [Abstract][Full Text] [Related]
8. 2-Azolylchromone Derivatives as Potent and Selective Inhibitors of Monoamine Oxidases A and B.
Takao K; Saito T; Chikuda D; Sugita Y
Chem Pharm Bull (Tokyo); 2016; 64(10):1499-1504. PubMed ID: 27725503
[TBL] [Abstract][Full Text] [Related]
9. Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins.
Carotti A; Altomare C; Catto M; Gnerre C; Summo L; De Marco A; Rose S; Jenner P; Testa B
Chem Biodivers; 2006 Feb; 3(2):134-49. PubMed ID: 17193252
[TBL] [Abstract][Full Text] [Related]
10. Novel 2H-chromen-2-one derivatives of resveratrol: Design, synthesis, modeling and use as human monoamine oxidase inhibitors.
Ruan BF; Cheng HJ; Ren J; Li HL; Guo LL; Zhang XX; Liao C
Eur J Med Chem; 2015 Oct; 103():185-90. PubMed ID: 26352677
[TBL] [Abstract][Full Text] [Related]
11. Selected chromone derivatives as inhibitors of monoamine oxidase.
Legoabe LJ; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2012 Sep; 22(17):5480-4. PubMed ID: 22850212
[TBL] [Abstract][Full Text] [Related]
12. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
[TBL] [Abstract][Full Text] [Related]
13. Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review.
Mathew B; Mathew GE; Petzer JP; Petzer A
Comb Chem High Throughput Screen; 2017; 20(6):522-532. PubMed ID: 28245770
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives.
Meiring L; Petzer JP; Petzer A
Bioorg Med Chem Lett; 2013 Oct; 23(20):5498-502. PubMed ID: 24012182
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs.
Gnerre C; Catto M; Leonetti F; Weber P; Carrupt PA; Altomare C; Carotti A; Testa B
J Med Chem; 2000 Dec; 43(25):4747-58. PubMed ID: 11123983
[TBL] [Abstract][Full Text] [Related]
17. Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors.
Gaspar A; Silva T; Yáñez M; Vina D; Orallo F; Ortuso F; Uriarte E; Alcaro S; Borges F
J Med Chem; 2011 Jul; 54(14):5165-73. PubMed ID: 21696156
[TBL] [Abstract][Full Text] [Related]
18. Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.
Gaspar A; Reis J; Fonseca A; Milhazes N; Viña D; Uriarte E; Borges F
Bioorg Med Chem Lett; 2011 Jan; 21(2):707-9. PubMed ID: 21194943
[TBL] [Abstract][Full Text] [Related]
19. Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study.
Matos MJ; Vilar S; Gonzalez-Franco RM; Uriarte E; Santana L; Friedman C; Tatonetti NP; Viña D; Fontenla JA
Eur J Med Chem; 2013 May; 63():151-61. PubMed ID: 23474901
[TBL] [Abstract][Full Text] [Related]
20. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
